thiophene-2,5-diyl)-bis(2-bromo-ethanone) (1) are described.
Introduction
We have been interested for some time in the chemical and biological properties of thienothiophene derivatives [1] [2] [3] . Thienothiophenes have been developed for different purposes in the pharmaceutical field and have been tested as potential antitumor, antiviral, antibiotic and antiglaucoma drugs or as inhibitors of platelet aggregation [3] [4] [5] [6] [7] [8] . In addition, thienothiophenes find potential applications in a wide variety of optical and electronic systems [9] [10] [11] . Recently, some conjugated thienothiophenes, structurally related to several current applications have been reported [12] [13] [14] [15] [16] [17] [18] [19] . In continuation of these findings, we report herein the synthesis of some novel bis-heterocycles containing a
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thieno [2,3-b] thiophene moiety as a base unit and which are of interest as potential biologically active compounds or pharmaceuticals.
Results and Discussion
The synthetic procedures adopted to obtain the target compounds are outlined in Schemes 1, 2 and 3. Treatment of bis-2-bromoacetylthieno[2,3-b]thiophene derivative 1 [3] with urea, thiourea or guanidine in refluxing EtOH/TEA gave the novel bisthieno [2,3-b] thiophene derivatives 2a-c, respectively (Scheme 1). The structures of the products were deduced from their elemental analysis and spectral data. For example, the 1 H-NMR spectrum of compound 2a revealed a singlet at δ 7.19 characteristic of an oxazole CH proton. The IR spectra of 2a-c showed, in each case, the absence of the carbonyl bands found in 1 and the presence of new bands in the 3422-3385 cm -1 region due to NH 2 and NH groups. In a similar manner, when 1 was treated with 2-aminobenzimidazole, the corresponding compound 7 was obtained in high yield.
Scheme 2. Synthesis of bis-thieno-thiophenes derivatives 4 and 5.
Scheme 3. Synthesis of bis-imidazole derivatives 6 and 7.
Experimental

General
All melting points were measured on a Koffler block melting point apparatus. IR spectra were measured as KBr pellets on a Perkin Elmer FT 1000 spectrophotometer. The NMR spectra were recorded in DMSO-d 6 on a Varian Mercury Jeol-(400 MHz) NMR spectrometer.
1 H-NMR (400 MHz) and 13 C-NMR were run in (DMSO-d 6 ). Chemical shifts were related to that of the residual solvent peak. Mass spectra were recorded on a Shimadzu GCMS-QP 1000 EX mass spectrometer at 70 eV. Elemental analyses were carried out at the Microanalytical Center of King Saud University, Riyadh, Saudi Arabia.
General Procedure for the Reaction of Bis-2-Bromoethanone Derivative 1 with Urea, Thiourea and Guanidine: Preparation of Compounds 2a-c
Compound 1 (0.410 g, 1 mmol) was treated with urea, thiourea or guanidine (2 mmol) in dry ethanol (20 mL, 99.9%) under reflux for 4-6 h. After addition of TEA (0.5 mL) the corresponding derivatives 2a-c were formed as solids that were filtered off, washed with ethanol, dried and recrystallized (DMF/EtOH) to afford the desired product in pure form. 
4,4'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis(oxazole-2-amine) (2a
4,4'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis(thiazol-2-amine) (2b
4,4'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis(1H-imidazol-2-amine) (2c
General Procedure for the Reaction of Bis-2-Bromoethanone Derivative 1 wih Aniline and 2-Aminopyrimidine
Treatment of compound 1 (0.410 g, 1 mmol) with aniline or 2-aminopyrimidine (2 mmol) in dry ethanol (20 mL 99.9%) at reflux for 5-8 h afforded the corresponding derivatives 4 and 5, respectively. The solid products formed were filtered off, washed with ethanol, dried and recrystallized (DMF/EtOH). 2'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis((3a)H-indole) [1,2-b] [1, 2, 4] triazole (6) . Compound 1 (0.410 g, 1 mmol), was added to 4-amino-1,2,4-triazole (0.168 g, 2 mmol) in dry ethanol (20 mL, 99.9%) at reflux for 4 h. After adding TEA (0.5 mL), two minutes of heating followed. The solid product formed was filtered off, washed with ethanol, dried and recrystallized (DMF/EtOH 
2,
5,5'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis(1H-imidazo
